Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.97B.
ENTERPRISE VALUE (EV)
$1.97B
Vericel Corporation
Market Cap
$2.05B
Enterprise Value (EV)
$1.97B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vericel Corporation (VCEL) | $2.05B | $1.97B |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.07B | $2.03B |
| Progyny, Inc. (PGNY)vs › | $2.03B | $1.91B |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.07B | $2.15B |
| Alvotech (ALVO)vs › | $2.08B | $3.39B |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | $2.14B |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | $1.90B |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.01B | $2.26B |
| Vera Therapeutics, Inc. (VERA)vs › | $2.10B | $2.13B |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | $2.12B |
Market Cap
$2.05B
Total Debt
$14.09M
Cash
$100.09M
Enterprise Value
$1.97B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
